Replies to post #30749 on RemSleep Holdings Inc (RMSL)

[MouthBreather]

the 2021 submission was not with empirical though. the 2022 submission was with empirical. and though they were beating around the bush with the cytotoxicity reports/labs etc, they wouldn't have resubmitted if that issue wasnt resolved. Again, not trying to go against you, just trying to understand the pessimism, i just want to make some money. seems to me like they are trying to move on from their unsteady past, maybe this submission will do that.....we shall see....hypothetically, if the submission passes, where do you see the SP going? and if it fails, obviously it will dump